Drug Shortage Report for SANDOZ MOXIFLOXACIN
| Report ID | 119335 |
| Drug Identification Number | 02411520 |
| Brand name | SANDOZ MOXIFLOXACIN |
| Common or Proper name | SANDOZ MOXIFLOXACIN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | MOXIFLOXACIN |
| Strength(s) | 0.5% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 3 ML LDP CA |
| ATC code | S01AE |
| ATC description | ANTIINFECTIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-06-26 |
| Estimated end date | 2020-09-11 |
| Actual end date | 2020-09-18 |
| Shortage status | Resolved |
| Updated date | 2020-09-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-09-21 | French | Compare |
| v3 | 2020-09-21 | English | Compare |
| v2 | 2020-07-02 | French | Compare |
| v1 | 2020-07-02 | English | Compare |
Showing 1 to 4 of 4